NCP Flanders
choose your programme
Horizon Europe

Horizon Europe is the main Research and Innovation Funding Programme of the European Commission.

Horizon 2020

Horizon 2020 is the previous Funding Programme. There are no longer calls, but projects can run until 2024.

Digital Europe

Digital Europe is a Funding Programme focused on bringing digital technology to businesses, citizens and administrations.

Other EU Funding

There are many other relevant EU funding programmes, managed by several agencies and directorates.

Event Calendar

Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020

Webinar on Safe & Sustainable by Design Framework (SSbD)

JUN
Thu
20
14:00 - 15:00

This was 6 months ago

Location

online

Programmes

NCP Flanders organises this webinar on the Safe and Sustainable by Design Framework: a guidance to scientists developing new chemicals or materials with the aim to make these safer and more sustainable.

It aims to

  • steer the innovation process towards the green and sustainable industrial transition
  • substitute or minimise the production and use of substances of concern, in line with, and beyond existing and upcoming regulatory obligations
  • minimise the impact on health, climate and the environment during sourcing, production, use and end-of-life of chemicals, materials and products

The Commission Recommendation from 8 December 2022 which announced the Framework reaches beyond HE projects, encouraging also national programmes to take up or industry to apply the framework when developing new chemicals or materials.

A representative of DG Research & Innovation from the European Commission will speak about the purpose of the framework, how it is to be used as part of a projects technical activities and the current status of the testing phase.

In a second part an expert from the Flemish Institute for Technological Research (VITO) will shed some light on the content of the SSbD framework.

There will be time for Q&A at the end of the presentations.

For registration (mandatory) click here.

myOVERVIEW
- sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.